Leonardo Basso

Leonardo Basso is a researcher at the University of Chile known for his work in health technology assessment (HTA). He gained attention for his contributions to the introduction of a promising medication against respiratory syncytial virus in Chile, making it the first country in the Southern Hemisphere to do so in 2023. His research emphasized the importance of evidence-based decision-making in public health policy, showcasing how HTA can guide sustainable healthcare spending.